Back in 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options. These most recent recalls focus on a series of maintenance issues that have already been addressed.

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

According to attorneys representing a potential class action of plaintiffs, Sharp HealthCare was not forthcoming about its use of a tool for automatic note-taking. The technology allegedly captures everything said in an exam room, including sensitive details on diagnoses, and sends it to an offsite server.